Sentence examples for different types of endpoints from inspiring English sources

Existing probabilistic approaches differ for different types of endpoints or modes-of-action, lacking a unifying framework.

For the gene signatures listed in Table 1, it should be pointed out that they were constructed using different types of endpoints, along with differing supervised learning algorithms.

The different types of endpoints will be presented with a focus on postoperative pain in the following section.

Where more thought and research is required is how to combine results from different types of endpoint.

DFS: disease-free survival; RFS: relapse-free survival; TTF: time to treatment failure; TTR: time to recurrence; CSS: cancer-specific survival; OS: overall survival When comparing the survival curves of different types of endpoint in patients treated with curative intention it was observed that TTR initially has a steeper slope than CSS, but that the curves merge with time.

We introduce a relative importance-based weighting approach for both origins and destinations that can be applied to different types of nodes including generic link endpoints that represent individual intersections and roadway segments in GIS-based roadway maps as well as to physical locations.

Second, given the multitude of endpoints included, and different types of studies involved, the assessment of eligibility for inclusion of potential studies required some degree of subjective judgement.

This would provide a more proficient way of testing the Xpert® MTB/RIF assay in different types of per-endoscopic respiratory samples, an endpoint that we were unable to analyze due to our retrospective design.

More recently, Anderson and Kodukula [ 3] provided some definitions of different types of biomarkers (e.g., surrogate, clinical endpoint, diagnostic, prognostic, predictive, pharmacodynamic, efficacy, and toxicity/safety [ 4– 6]) within their review of the role of biomarkers in pharmacology and drug discovery.

Medians and ranges were calculated overall for the different types of trial and then broken down by endpoint and whether the trial was public or industry funded.

Conversely, we expected that the dose-response kinetics of BaP-induced micronucleus formation would be different, given that this cytogenetic damage endpoint is sensitive to different types of lesions.